Adverum Biotechnologies Surpasses Analysts' Expectations with GAAP EPS of -$0.23
Monday, 18 March 2024, 20:35
Adverum Biotechnologies Financial Update
Adverum Biotechnologies has recently reported its GAAP EPS results, outperforming market forecasts. The company's earnings per share of -$0.23 surpassed expectations by $0.11, showcasing a positive financial performance for the biotechnology firm.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.